6 hours Ago
DUBLIN , Nov. 25, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS ) announced today that management will participate in two upcoming investor conferences. 7 th Annual Evercore ISI HealthCONx Conference Date/Time: Tuesday, Dec .
3, 2024 at 10:25 a.m. ET ( 3:25 p.
m. GMT ) Piper Sandler 36 th Annual Healthcare Conference Date/Time: Wednesday, Dec . 4, 2024 at 4:00 p.
m. ET ( 9:00 p.m.
GMT ) The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
About Alkermes plc Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia . Headquartered in Ireland , Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio .
For more information, please visit Alkermes ' website at www.alkermes.com .
Alkermes Contact: Jamie Constantine Investor Relations +1 781 873 2402 SOURCE Alkermes plc.
